9-ING-41, a GSK-3 beta-selective small molecule inhibitor, in combination with ruxolitinib in JAK2617F primary myelofibrosis-MedSci.cn

9-ING-41, a GSK-3 beta-selective small molecule inhibitor, in combination with ruxolitinib in JAK2617F primary myelofibrosis

Lasho, TL; Giles, F; Finke, C; Gangat, N; Tefferi, A

CANCER RESEARCH, 2020; 80 (16):

科室
- - 订阅+
  - 更多科室
工具
服务